SI0785950T1 - Keratinocyte growth factor analogs - Google Patents

Keratinocyte growth factor analogs

Info

Publication number
SI0785950T1
SI0785950T1 SI9530653T SI9530653T SI0785950T1 SI 0785950 T1 SI0785950 T1 SI 0785950T1 SI 9530653 T SI9530653 T SI 9530653T SI 9530653 T SI9530653 T SI 9530653T SI 0785950 T1 SI0785950 T1 SI 0785950T1
Authority
SI
Slovenia
Prior art keywords
growth factor
keratinocyte growth
factor analogs
analogs
kgf
Prior art date
Application number
SI9530653T
Other languages
English (en)
Slovenian (sl)
Inventor
Bao-Lu Chen
Tsutomu Arakawa
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of SI0785950T1 publication Critical patent/SI0785950T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9530653T 1994-10-13 1995-10-12 Keratinocyte growth factor analogs SI0785950T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32333794A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/US1995/013075 WO1996011951A2 (en) 1994-10-13 1995-10-12 Keratinocyte growth factor analogs
EP95938216A EP0785950B1 (de) 1994-10-13 1995-10-12 Analogen des keratinozytenwachstumfaktors

Publications (1)

Publication Number Publication Date
SI0785950T1 true SI0785950T1 (en) 2003-08-31

Family

ID=26983900

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530653T SI0785950T1 (en) 1994-10-13 1995-10-12 Keratinocyte growth factor analogs

Country Status (14)

Country Link
EP (1) EP0785950B1 (de)
JP (2) JP4422210B2 (de)
AT (1) ATE237634T1 (de)
AU (1) AU3893195A (de)
CA (1) CA2202390C (de)
DE (1) DE69530404T2 (de)
DK (1) DK0785950T3 (de)
ES (1) ES2196088T3 (de)
HU (1) HUT78069A (de)
MX (1) MX9702665A (de)
NO (1) NO971621L (de)
PT (1) PT785950E (de)
SI (1) SI0785950T1 (de)
WO (1) WO1996011951A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ343795A3 (en) 1993-06-29 1996-07-17 Chiron Corp Shortened keratinocyte growth factor /kgf/ exhibiting increased biological activity
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
ES2197926T3 (es) * 1994-10-13 2004-01-16 Amgen Inc. Metodo para purificar factores de crecimiento de queratinocitos.
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) * 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
EP0938499A1 (de) 1996-07-19 1999-09-01 Amgen Inc. Analoge von kationische proteine
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
SI0935652T1 (en) * 1996-10-15 2004-06-30 Amgen Inc. Keratinocyte growth factor-2 products
DE69728415T2 (de) * 1996-10-15 2004-08-12 Amgen Inc., Thousand Oaks Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
KR20010033484A (ko) * 1997-12-22 2001-04-25 휴먼 게놈 사이언시즈, 인크. 각질세포 성장 인자-2 제제
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
MXPA04001526A (es) 2001-08-21 2004-05-31 Chiron Corp Composiciones de polipetidos kgf.
US8304387B2 (en) 2004-12-15 2012-11-06 Swedish Orphan Biovitrum Ab (Publ) Therapeutic formulations of keratinocyte growth factor
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197800T1 (de) * 1989-01-31 2000-12-15 Jeffrey S Rubin Dns kodierend für einen für epithelzellen spezifischen wachstumsfaktor
NZ274667A (en) * 1993-09-24 1997-03-24 American Cyanamid Co Fibroblast growth factor analogue

Also Published As

Publication number Publication date
EP0785950A2 (de) 1997-07-30
MX9702665A (es) 1997-07-31
ES2196088T3 (es) 2003-12-16
CA2202390A1 (en) 1996-04-25
WO1996011951A3 (en) 1996-12-12
PT785950E (pt) 2003-09-30
ATE237634T1 (de) 2003-05-15
JP2007020575A (ja) 2007-02-01
JP2000511762A (ja) 2000-09-12
NO971621L (no) 1997-06-12
JP4422210B2 (ja) 2010-02-24
CA2202390C (en) 2005-05-17
DE69530404T2 (de) 2003-11-13
HUT78069A (hu) 1999-08-30
DK0785950T3 (da) 2003-07-28
WO1996011951A2 (en) 1996-04-25
AU3893195A (en) 1996-05-06
EP0785950B1 (de) 2003-04-16
DE69530404D1 (de) 2003-05-22
NO971621D0 (no) 1997-04-09

Similar Documents

Publication Publication Date Title
MX9702665A (es) Analogos del factor de crecimiento de queratinocitos.
BG101408A (en) Analogs of keratinocyte growth factor
AU6286986A (en) Peptide analogues of mammalian insulin-like growth factor-1
AU7550098A (en) System for expressing hyperthermostable protein
MY123740A (en) Il-13 receptor polypeptide
ES2000216A6 (es) Procedimiento para preparar un polipeptido purificado que tiene propiedades inhibidoras de la coagulacion de la sangre.
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
HUT76668A (en) Novel process for the production of biologically active dimeric protein
AU3258197A (en) Peptides
CA2201944A1 (en) Analogs of keratinocyte growth factor having enhanced temperature stability
CA2133834A1 (en) Process for preparing modified proteins
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
EP0249412A3 (en) C-terminal alpha-amidating enzyme and process for production and use thereof
NZ511618A (en) Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X
GR3021408T3 (en) Cloning of a new member of the fibroblast growth factor (fgf) receptor family
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
EP0625580A4 (en) Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient.
EP1158052A4 (de) Beta-primeverosidase gen
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.